A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective-Reference-Cited by-同舟云学术

A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective

Published:2010-04 Issue:4 Volume:32 Page:717-728
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Nuijten Mark,Mittendorf Thomas

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Multiple sclerosis and other demyelinating diseases;Hauser,1998

2. Harrison's Principles of Internal Medicine,1998

3. Multiple sclerosis;Noseworthy;N Engl J Med,2000

4. The natural history of multiple sclerosis: A geographically-based study. 2. Predictive value of the early clinical course;Weinshenker;Brain,1989

5. Neuroimaging evaluation in multiple sclerosis;Rieumont;Am Fam Physician,1993

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Literatur;Multiple Sklerose;2022

2. How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review;Neurology and Therapy;2021-07-19

3. Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review;Expert Review of Pharmacoeconomics & Outcomes Research;2021-02-02

4. Modelling expenses for multiple sclerosis treatment;Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology);2020-06-01

5. Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review;FARM HOSP;2020